Real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir in hospitalized patients with COVID‐19: A retrospective cohort study

G Deng, D Li, Y Sun, L Jin, Q Zhou… - Journal of medical …, 2023 - Wiley Online Library
Chinese guidelines prioritize the use of Azvudine and nirmatrelvir–ritonavir in COVID‐19
patients. Nevertheless, the real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir …
被引用次数：36 相关文章

Real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir in hospitalized patients with COVID‐19: A retrospective cohort study.

G Deng, D Li, Y Sun, L Jin, Q Zhou… - Journal of Medical …, 2023 - search.ebscohost.com
Chinese guidelines prioritize the use of Azvudine and nirmatrelvir–ritonavir in COVID‐19
patients. Nevertheless, the real‐world effectiveness of Azvudine versus nirmatrelvir–ritonavir …

Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study

G Deng, D Li, Y Sun, L Jin, Q Zhou… - Journal of medical …, 2023 - pubmed.ncbi.nlm.nih.gov
Chinese guidelines prioritize the use of Azvudine and nirmatrelvir-ritonavir in COVID-19
patients. Nevertheless, the real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir …

Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.

G Deng, D Li, Y Sun, L Jin, Q Zhou, C Xiao… - Journal of Medical …, 2023 - europepmc.org
Chinese guidelines prioritize the use of Azvudine and nirmatrelvir-ritonavir in COVID-19
patients. Nevertheless, the real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir …